Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001171843-25-000195

CEO gave up 58,054 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schuetz Thomas J. CEO 2025-01-09 Shares withheld for taxes −58,054 $1.86 $107,980 6,512,512 D
Loading xslF345X05/ownership.xml…